These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14754655)

  • 1. 0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus.
    Drüke A; Gambichler T; Altmeyer P; Freitag M; Kreuter A
    J Dermatolog Treat; 2004 Jan; 15(1):63-4. PubMed ID: 14754655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Topical treatment with tacrolimus in lupus erythematosus tumidus].
    Bacman D; Tanbajewa A; Megahed M; Ruzicka T; Kuhn A
    Hautarzt; 2003 Oct; 54(10):977-9. PubMed ID: 14513247
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical treatment of subacute-cutaneous lupus erythematosus with tacrolimus].
    Meller S; Bruch-Gerharz D; Ruzicka T; Homey B
    Hautarzt; 2005 Apr; 56(4):368-9. PubMed ID: 15750673
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
    Tzellos TG; Kouvelas D
    Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases.
    Böhm M; Gaubitz M; Luger TA; Metze D; Bonsmann G
    Dermatology; 2003; 207(4):381-5. PubMed ID: 14657631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study.
    Tzung TY; Liu YS; Chang HW
    Br J Dermatol; 2007 Jan; 156(1):191-2. PubMed ID: 17199600
    [No Abstract]   [Full Text] [Related]  

  • 8. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
    Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
    J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
    Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
    J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.
    Tatlican S; Eren C; Atacan D; Dalgic U; Canpolat F; Eskioglu F
    J Dermatolog Treat; 2010 Sep; 21(5):322-3. PubMed ID: 19832287
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus.
    von Pelchrzim R; Schmook T; Friedrich M; Worm M
    Int J Dermatol; 2006 Jan; 45(1):84-5. PubMed ID: 16426386
    [No Abstract]   [Full Text] [Related]  

  • 12. [Light induced subacute cutaneous lupus erythematodes: diagnosis and management].
    Haust M; Meller S; Bruch-Gerharz D; Homey B
    Hautarzt; 2007 Oct; 58(10):828-30. PubMed ID: 17828379
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial.
    Kuhn A; Gensch K; Haust M; Schneider SW; Bonsmann G; Gaebelein-Wissing N; Lehmann P; Wons A; Reitmeir P; Ruland V; Luger TA; Ruzicka T
    J Am Acad Dermatol; 2011 Jul; 65(1):54-64, 64.e1-2. PubMed ID: 21501887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
    Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
    Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lichenified atopic eczema with tacrolimus ointment.
    Granlund H; Remitz A; Kyllönen H; Lauerma AI; Reitamo S
    Acta Derm Venereol; 2001; 81(4):314-5. PubMed ID: 11720192
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus.
    Penha MÁ; Libório RDS; Miot HA
    An Bras Dermatol; 2018 Jun; 93(3):467-469. PubMed ID: 29924233
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality Testing of Tacrolimus Ointment Mixed with Various Type of Ointments or Creams.
    Nakane T; Doi H; Hirohara M; Hamashima H; Inoue Y
    Biol Pharm Bull; 2018; 41(11):1632-1637. PubMed ID: 30381662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clearance of linear porokeratosis with tacrolimus, 0.1%, ointment.
    Parks AC; Conner KJ; Armstrong CA
    JAMA Dermatol; 2014 Feb; 150(2):194-6. PubMed ID: 24553841
    [No Abstract]   [Full Text] [Related]  

  • 19. 0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus.
    Heffernan MP; Nelson MM; Smith DI; Chung JH
    Arch Dermatol; 2005 Sep; 141(9):1170-1. PubMed ID: 16172325
    [No Abstract]   [Full Text] [Related]  

  • 20. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.
    Kontos AP; Kerr HA; Fivenson DP; Remishofsky C; Jacobsen G
    Int J Dermatol; 2006 Nov; 45(11):1383-5. PubMed ID: 17076739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.